Author Archives: user

Lowell Therapeutics, Inc. to present at The Biotech Showcase™ 2020

Quoted from Reportable News: San Francisco/January 12, 2020 – Lowell Therapeutics, Inc., (Lowell) today announced that it has scheduled a company presentation at the Biotech Showcase™ 2020, to be held January 13-15, during the most important week in healthcare at the Hilton San Francisco Union Square. James Wilkie, President & CEO will be presenting Lowell […]

Niyad Granted Breakthrough Device Designation by FDA

Lowell Therapeutics (LTX) today announced that the FDA has granted Breakthrough Device Designation for Niyad. Niyad provides anticoagulation for patients in the ICU on an artificial kidney machine. When commercialized, Niyad will be the only FDA-approved regional anticoagulant and provides an option for anticoagulation that does not exist today and is an improvement over the […]

Lowell Therapeutics, Inc. To Present at The M2D2 Conference – September 2020

BOSTON, Sept. 14, 2020 — Lowell Therapeutics, Inc. (LTX), a biopharmaceutical company, announced today that the company has been selected by the M2D2 Center of the University of Massachusetts as a finalist in its annual competition of rising stars in the biotech community. James Wilkie, President & CEO, will provide a corporate overview on Thursday, […]